Genetic alterations in human BCL9 genes have repeatedly been found in congenital heart disease (CHD) with as-of-yet unclear causality. BCL9 proteins and their Pygopus (Pygo) co-factors can participate in canonical Wnt signaling via binding to β-catenin. Nonetheless, their contributions to vertebrate heart development remain uncharted. Here, combining zebrafish and mouse genetics, we document tissuespecific functions in canonical Wnt signaling for BCL9 and Pygo proteins during heart development. In a CRISPR-Cas9-based genotype-phenotype association screen, we uncovered that zebrafish mutants for bcl9 and pygo genes largely retain β-catenin activity, yet develop cardiac malformations. In mouse, both systemic and lineage-specific loss of the Pygo-BCL9-β-catenin complex caused heart defects with outflow tract malformations, aberrant cardiac septation and valve formation, and compact myocardium hypoplasia.
Introduction
Congenital heart diseases (CHD) are the most frequent human birth defects (affecting ca. 0.8% of live births) and can result in perinatal lethality or life-long complications despite increasingly successful surgical interventions 1 . Understanding the molecular details of heart development is imperative for discovering the causes of CHD. The heart is the first functional organ in the developing vertebrate embryo. It initially forms as a linear tube from the anterior lateral plate mesoderm (LPM) before undergoing extensive remodeling and looping 2 . Addition of second heart field (SHF)-assigned late-differentiating LPM expands the heart and triggers the formation of the right ventricle and atria in mammals 3 . Migrating cardiac neural crest cells (CNC) have further been implicated in contributing to heart formation, in particular by populating the outflow tract (OFT) 4 .
Mutations in various genomic loci, in particular in cardiac transcription factor genes including GATA4, TBX5, MSX1, or HAND1/2, have been linked to familial CHD 5 and have become functionally associated with CHD phenotypes by genetic studies in model organisms 6 . Nonetheless, the predominant number of spontaneous CHD cases with identified sequence alterations do not feature clear recessive loss-offunction mutations, but are frequently heterozygous for mutations or harbor copy number variations (CNVs) with amplifications and deletions of genomic regions encompassing several genes 7, 8 . Markedly, while heterozygous perturbations seem sufficient to cause CHDs in humans, mutations in CHD-implicated genes in mouse and zebrafish frequently act as recessive trait 9, 10 . These observations indicate that human cardiac development might be particularly sensitive to alterations in gene dosage.
Canonical Wnt signaling contributes to numerous developmental processes, including heart formation, by controlling the nuclear role of β-catenin as transcriptional regulator and its cooperation with tissuespecific transcription factors 11, 12 . β-catenin activity directs proliferation and cell fate commitment at different stages and in different cell types during heart formation. During gastrulation, canonical Wnt signaling promotes mesoderm formation, while its inhibition is subsequently required for LPM induction into early cardiac precursors 13 . Early cardiomyocytes display a robust proliferative response to canonical Wnt signaling and, conversely, accelerated differentiation upon pathway inhibition 14 . Several phases of canonical Wnt signaling are guiding the interplay of endocardial and myocardial layers to form functional heart valves 13, 15 . Canonical Wnt signaling has also been linked to enhanced proliferation of SHF cells and to the control of CNC cells that both contribute to the mammalian OFT [16] [17] [18] [19] . How canonical Wnt signaling elicits tissue-specific responses through the seemingly universal action of β-catenin in target gene control remains incompletely understood.
Nuclear β-catenin orchestrates canonical Wnt target-gene expression by recruiting a host of co-factors to Wnt-responsive elements (WREs) occupied by TCF/LEF transcription factors 20, 21 . In Drosophila, the coupling of the histone code-reader plant homology domain (PHD) finger protein Pygopus (Pygo) via the adaptor protein Legless (Lgs) to the β-catenin N-terminal Armadillo repeats is necessary for virtually all canonical Wnt signaling-dependent responses [22] [23] [24] . Vertebrate genomes commonly harbor two paralogs of lgs, Bcl9 and Bcl9l (Bcl9/9l), and two of pygo, Pygo1 and Pygo2 (Pygo1/2). Morpholino antisense experiments and overexpression have suggested functions in β-catenin-associated axis formation during gastrulation in Xenopus and zebrafish 25, 26 . Nonetheless, genetic loss-of-function in the mouse has questioned their relevance for canonical Wnt signaling in mammals: neither the compound deletion of Bcl9/9l nor the deletion of Pygo1/2 causes a general abrogation of canonical Wnt signaling in mouse development [27] [28] [29] [30] . Mouse mutant analysis has further emphasized that BCL9 and Pygo proteins have evolved β-catenin-independent and even cytoplasmic functions in mammals, including the genetic interaction with Pax6 during eye lens formation and cytoplasmic functions in enamel formation during tooth development [29] [30] [31] . Biochemical evidence further suggests that Pygo-BCL9 act as connecting factors of chromatin-engaged complexes 23 . Whether and to what extent BCL9/9L and Pygo1/2 at all contribute to βcatenin-dependent transcription during mammalian development remains to be resolved [27] [28] [29] 31 . Alterations in BCL9 have been repeatedly associated with disease states; most notably, CNVs with locus gains and losses of the human chromosome 1q21.1 locus, to which BCL9 maps to, are repeatedly found in cases of CHD [32] [33] [34] [35] [36] [37] [38] , while mutant BCL9L has been linked to heart-affecting heterotaxia 39 . If and what role BCL9 plays during heart formation remains unaddressed.
Here, we provide evidence that BCL9 and Pygo proteins contribute as tissue-specific mediators of βcatenin activity to vertebrate heart formation. Following a CRISPR-Cas9-based phenotype screen of CHDimplicated candidate genes in zebrafish, we uncovered that mutating the Pygo-BCL9-β-catenin complex causes impaired heart formation. Late developmental defects of bcl9 and pygo1/2 mutants are phenocopied by selective chemical inhibition of the BCL9-β-catenin interaction when perturbation is initiated before, during, or after gastrulation. In the mouse heart, we uncovered septation, OFT, and valve defects by both constitutive and heart-specific conditional loss of Bcl9/9l or Pygo1/2, or by simultaneous impairment of the BCL9/9L-β-catenin and BCL9/9L-PYGO2 interactions. Transcriptome and chromatin binding analyses established that the PYGO-BCL9-β-catenin complex contributes to the regulation of key factors involved in cardiac patterning and OFT and heart valve formation, including Pitx2, Hand2, Prrx1 and Msx1. Collectively, our results provide functional and molecular evidence for a conserved tissuespecific function of the BCL9 and Pygo factors in canonical Wnt signaling in vertebrates. These findings further suggest a causative link between human CHDs and copy number changes in BCL9 at 1q21.1 and mutations reported in BCL9L that can potentially perturb the expression of heart-specific canonical Wnt target genes during cardiac development.
Results

BCL9 and Pygo perturbations cause developmental heart defects in zebrafish
To identify regulators of vertebrate heart formation implicated in chromosomal amplifications and deletions found in human CHDs, we performed an injection-based candidate gene screen in zebrafish using maximized CRISPR-Cas9-mediated mutagenesis in F0 crispants 40 (Figure 1a ). We targeted candidate genes with individual sgRNAs by injection of Cas9 ribonucleoprotein complexes into one-cell stage zebrafish embryos, and screened the resulting crispants for impaired heart development ( Figure  1a ). These efforts revealed that mutations in bcl9 lead to pericardial edema within the first 120 hpf of zebrafish development (Figure 1a ). We established heterozygous mutant zebrafish strains for both BCL9 family genes bcl9 and bcl9l, featuring frameshift deletions in-between the coding sequences for HD1 and HD2, the domains of BCL9 proteins that convey functional interaction with the interactors Pygo and βcatenin, respectively 22, 29 . We refer to these new alleles as bcl9 Δ29 and bcl9l Δ4 : if not null, their BCL9 protein products have impaired association with β-catenin (Figure 1b, Supplementary Figure 1 ). Heterozygous bcl9 Δ29 and homozygous bcl9l Δ4 zebrafish were viable and fertile with no obvious phenotypes (observed for more than 4 generations) ( Supplementary Figure 1 ). Contrary to previous conclusions based on morpholino-mediated knockdown 25 , this observation suggests that BCL9L does not contribute any essential functions in zebrafish under laboratory conditions. Zygotic-mutant embryos homozygous for bcl9 Δ29 developed seemingly normal until 48 hpf and did not show any misregulation of early cardiac markers at 24 hpf (Supplementary Figure 2 ). Between 56-72 hpf, while the hearts of homozygous bcl9 Δ29 mutants are beating and pattern into an atrial and ventricular chamber, we observed a variable incidence and expressivity of pericardial edema (38% ± 12) and misexpression of the cardiac valve marker vcana in mutant embryos (Supplementary Figure 3 ). By 5 days post fertilization (dpf), homozygous bcl9 Δ29 larvae showed highly penetrant craniofacial and cardiac defects (n=181/879, 20.6% compared to Mendelian 25%, N=6) ( Figure 1d Figure 4 ). Homozygous bcl9 Δ29 -mutant larvae also failed to properly inflate their swim bladder and died at 11-12 dpf. Homozygous bcl9 Δ29 ;bcl9l Δ4 double-mutant zebrafish embryos looked indistinguishable from homozygous bcl9 Δ29 mutants (Figure 1d f), confirming the non-essential function of bcl9l, and suggesting no significant genetic compensation 41 by the paralog bcl9l in bcl9 Δ29 mutants. BCL9/9L proteins act during Drosophila and vertebrate development via functional coupling with the histone-code reader Pygo 22, [42] [43] [44] . To test for a potential role of Pygo1/2 during zebrafish heart development, we generated pygo1 and pygo2 loss-of-function mutant alleles. These alleles harbor frameshift mutations within the essential NH2-terminal homology domain (NHD) and result in a premature Stop codon before the BCL9-binding C-terminal PHD domain; we refer to these alleles as pygo1 Δ5 and pygo2 Δ1 (Figure 2a c). Homozygous pygo1 Δ5 and homozygous pygo2 Δ1 zebrafish embryos were indistinguishable from wildtype siblings throughout development, and homozygous pygo1 Δ5 and homozygous pygo2 Δ1 zebrafish develop to fertile adults (Supplementary Figure 5 ). In contrast, embryos homozygous for pygo2 Δ1 and compound hetero-or homozygosity for pygo1 Δ5 displayed cardiac and craniofacial cartilage defects that recapitulated those observed in homozygous bcl9 Δ29 zebrafish mutants ( Supplementary Figures 4,5 ).
Taken together, these data reveal select post-gastrulation defects and sensitivity of cardiac development to functional BCL9 and Pygo levels in zebrafish.
BCL9 and PYGO are required for proper heart development in the mouse
In mouse, compound loss-of-function of Pygo1 and Pygo2 (Pygo1/2) leads to embryonic lethality at 13.5/14.5 days post-coitum (dpc) 27, 28 . Analysis of these mutants revealed that Pygo1/2-mutant mouse embryos develop severe heart defects between 10.5 and 14.5 dpc: histology and 3D reconstruction of the heart documented shorter and thinner atrio-ventricular valve leaflets, dilated atria, hypoplastic ventricular myocardium, and aberrant chamber septation (Figure 2f We subsequently tested the requirement of PYGO1/2 binding to BCL9/9L in heart formation by making use of Bcl9/9l alleles carrying a deletion in the region encoding the PYGO1/2-binding domain HD1 (Bcl9/9l-ΔHD1) 29 . Bcl9/9l-ΔHD1-homozygous mouse embryos died at the same stage as Pygo1/2 mutants (13.5-14.5 dpc), and histological sections revealed heart defects resembling those observed upon Pygo1/2 loss ( Figure 2n ,o). This result indicates that the cardiac defects observed in our mutant mice arise from perturbing the cooperative action of BCL9/9L and PYGO1/2.
Taken together, our analyses in mouse and zebrafish establish that perturbation of BCL9 and Pygo function cause defective cardiac development in two evolutionarily distant vertebrates.
The BCL9-Pygo complex drives Wnt/β-catenin signaling in the developing heart
Due to the β-catenin-independent roles of BCL9 and Pygo proteins [28] [29] [30] [31] , we cannot formally link the phenotypes resulting from our mutants to defective canonical Wnt signaling. Since BCL9/9L can act as linker proteins connecting β-catenin and PYGO 45 , we aimed at specifically testing the concurrent requirement of connecting these interaction partners.
We generated mice trans-heterozygous for alleles of Bcl9/9l in which either the HD1 (PYGO binding) or the HD2 (β-catenin binding) domains are deleted (Figure 3a Further relating these defects to perturbed canonical Wnt signaling was the reduced expression of the in vivo BATgal reporter (sensing nuclear β-catenin activity) in Bcl9/9l-ΔHD1/ΔHD2 mutants in cardiac valve progenitors, a region with active canonical Wnt signaling 46 (Figure 3d To independently perturb the protein-protein interaction between BCL9 and β-catenin in zebrafish, we used the chemical compound LH-2-40 that acts as selective inhibitor of the BCL9-HD2 interaction with the β-catenin Arm repeats 1-2 49 . We treated wildtype zebrafish embryos with LH-2-40 at concentrations ranging from 1 to 50 µM at distinct developmental time-points: 4 cell-stage, shield stage, and 18 somite stage, respectively. Pre-gastrulation-and gastrulation-stage treatment with LH-2-40 did not induce any observable gastrulation defects (Figure 4a Table 2 ). Moreover, several of the deregulated genes have been linked, in particular, to epithelial-to-mesenchymal transition (EMT) and to morphogenetic processes occurring during cardiac valve formation (Figure 5b , Supplementary Table 2 ). STRING analysis of our candidate gene list revealed medium-to-high confidence protein-protein interaction clusters related to cardiac valve formation ( Figure   5c ). While zebrafish do not form all structures found in the mammalian heart, this transcriptome profiling raised the possibility that BCL9, and by inference its connection with β-catenin and Pygo, are selectively required during specific aspects of vertebrate cardiac development. We therefore sought to complement our phenotype analysis of BCL9 and PYGO loss in cardiac development using conditional loss-of-function alleles in the mouse.
To test for the contribution of mouse BCL9 and PYGO in LPM-derived heart progenitors, we combined the Pygo-flox and Bcl9/9l-flox strains with Nkx2.5-Cre, in which Cre recombinase is active in the expression domain of the cardiac homeobox gene Nkx2.5 at early cardiac crescent stages (ca. 7.5 dpc) 51 . Nkx2.5-Cre-mediated Pygo1/2 or Bcl9/9l recombination led to embryonic lethality around 13.5 dpc, accompanied by cardiac malformations including thinner myocardium and aberrantly enlarged atrio-ventricular valves ( Figure 5d ,e). The effect on the compact myocardium upon Pygo1/2 or Bcl9/9l mutations is consistent with the role of canonical Wnt signaling in driving cardiomyocytes proliferation whilst preventing terminal maturation 52 . We confirmed that Wnt/β-catenin signaling, in this context, is dependent on PYGO proteins by performing a siRNA-mediated downregulation of Pygo2 in cultured murine embryonic cardiomyocytes ( Figure 5f ): Pygo2 knockdown in this system led to increased expression of the cardiomyocyte-specific genes Gja1 (Connexin43), Gata4, and Nkx2.5, indicating enhanced differentiation 52 . Taken together, these experiments reveal that the BCL9-PYGO complex is required in mesodermal cardiac lineages, and that cardiac mesoderm-specific loss recapitulates aspects of the heart phenotypes induced by constitutive Bcl9
and Pygo gene mutations.
In mammals and chick, CNC contributes to OFT development and septation 53, 54 . We tested the Taken together, these results establish that the BCL9-PYGO complex connected to β-catenin is required both in early mesodermal Nkx2.5-expressing cardiac progenitors and migrating CNC cells, the two key lineages whose interplay is crucial during heart development 59 .
The tripartite Pygo-BCL9-β-catenin complex controls cardiac regulators
Our combined data provides evidence that the Pygo-BCL9-β-catenin complex contributes to canonical Wnt signaling activity during selected developmental processes in the vertebrate embryo, in particular in the heart. We next sought to gain insight into the target genes controlled by the PYGO-BCL9-β-catenin module in the CNC-and mesoderm-derived cardiac lineages. We dissected mouse embryonic branchial arches 3-6, through which CNC progenitor cells migrate dorso-ventrally toward the heart cushion and OFT structures 13 , together with the developing heart tube, from constitutive Pygo1/2-mutant mice and control siblings at 10.5 dpc and performed RNA-seq (n=4, Figure 6a ). This analysis revealed a reproducible set of deregulated genes: among these, 65 (44 of which were downregulated and 21 upregulated) displayed high statistical significance (p-value<0.05, fold change <0,66 and >1.5) ( Figure 6b ). GO analysis associated a broader group of the most deregulated genes with cardiac ventricle development, embryonic limb morphogenesis and skeletal system development, recapitulating the biological processes perturbed upon bcl9 mutation in zebrafish ( Figure 6c ). We confirmed the downregulation of the most relevant genes by qRT-PCR and in situ hybridization (ISH) (Figure 6d ,e). Notably, the down-regulated genes comprised several genes encoding for mesodermal and NC transcription factors crucial for heart development,
including Pitx2, Hand2, Msx1, and Prrx1 16, 58, 60, 61 (Figure 6d ,e). RNA-seq of Pygo1/2-mutant hearts at 12.5 dpc when septation, valve formation, and myocardium proliferation and thickening have occurred 13 , showed more profound gene expression changes, with 1597 genes being deregulated (533 down, 1064 up, p-value<0.05, n=3). Consistent with progressive deterioration of cardiac development, the deregulated genes at 12.5 dpc fall into broader GO categories, including perturbed metabolic processes, protein translation, ribosome assembly, muscle formation, and increased regulation of programmed cell death (Supplementary Table 3 ). Several genes deregulated at 10.5 dpc, including Msx1, Prrx1 and Pitx2, are known regulators of tissue-specific gene regulatory networks 16, [61] [62] [63] [64] , suggesting that β-catenin, via PYGO-BCL9, directly controls a subset of these genes, and that their early perturbation leads to the multitude of deregulated cellular processes at 12.5 dpf as a secondary consequence.
To discover the genomic locations that are bound by the PYGO-BCL9-β-catenin complex, we performed chromatin immunoprecipitation followed by sequencing (ChIP-seq) for β-catenin and PYGO2 at 10.5 dpc from dissected pharyngeal arches 3-6 and the heart, as carried out for the transcriptome analysis ( Figure   7a ). ChIP-seq analysis assigned a total of 982 high-confidence genomic loci occupied by β-catenin, and 5252 by PYGO2 ( Figure 7b ); the broader chromatin association of PYGO2 is in line with the known role of these factors as broad chromatin code-readers 45, 65 and their Wnt-independent functions 28 . Nonetheless, co-occupancy of β-catenin and PYGO2 occurred at 59% of all β-catenin peaks (577/982). We focused our attention on these overlapping peaks, among which we found regions that mapped to the vicinity of canonical Wnt targets, including Axin2 and Lef1 (Figure 7c ). These regions corresponded to previously described Wnt-regulatory-elements (WRE) at these loci found in other cell types 66, 67 , and displayed the consensus binding sequence of the TCF/LEF transcription factors ( Figure 7d Collectively, our data support the notion that a subset of heart-specific transcriptional regulators is controlled by BCL9 and Pygo as a consequence of their context-dependent interaction with β-catenin.
Discussion
Numerous proteins have been shown to function with nuclear β-catenin, but only few are considered universal core components of the canonical Wnt pathway. Contrary to the mandatory requirement in Drosophila 23,65 , genetic evidence in mammals has questioned the significance and involvement of BCL9mediated tethering of the histone reader Pygo to β-catenin in Wnt target gene control [29] [30] [31] . Here, by combining in vivo analyses in zebrafish and mouse, we revealed a conserved contribution of BCL9 and Pygo proteins as context-dependent regulators of Wnt/β-catenin signaling in vertebrates, in particular during heart development. Our in vivo data clarifies, consolidates, and extends previous work in several models on BCL9 and Pygo protein function. Additionally, our results implicate perturbed BCL9/9L levels as potentially causative for human CHDs, as it occurs in copy number variants of 1q21.1.
Biochemical and cell culture-based evidence has linked the BCL9-Pygo complex to a variety of nuclear processes independent of β-catenin and TCF. In parallel, in vivo evidence for BCL9 and Pygo function has suggested divergent functions for these proteins in mammals versus fishes and amphibians: while overexpression and morpholino-based experiments in zebrafish and Xenopus have assigned β-catenindependent functions for BCL9 and Pygo proteins already during gastrulation, loss-of-function studies during mouse development have uncovered mainly Wnt-independent phenotypes 25, 26, 29 . To date, no clear consensus of their function during vertebrate development has emerged. By using genetic and chemical loss-of-function studies both in zebrafish and mouse, we define the in vivo requirement of BCL9 and Pygo during vertebrate development, and specifically their role in relation to β-catenin. The phenotypes resulting from abrogating their function imply that the Pygo-BCL9-β-catenin complex, while being dispensable during early embryogenesis, is fundamental as context-dependent transcriptional regulator during several tissue-specific processes, in particular during heart development.
We corroborate this conclusion by several lines of evidence. Previous work and our results confirm that various genetic loss-of-function permutations of BCL9 and PYGO proteins do not perturb gastrulation in mouse 29 (Figures 2 and 3 ). In zebrafish, using CRISPR-Cas9, we generated mutants with a premature stop codon between the HD1 and HD2 coding sequence of bcl9 and bcl9l; these mutations should uncouple BCL9/9L-PYGO1/2 from engaging with β-catenin. Zebrafish Bcl9 and Bcl9l are maternally contributed, yet we failed to detect any gastrulation defects previously reported for morpholino knockdown of Xenopus XBcl9 and zebrafish bcl9l 25, 26 . We substantiated this conclusions in three experimental setups: i) both zygotic and maternal-zygotic bcl9l ∆4/∆4 homozygous mutants are viable and fertile (Supplementary presumably due to a more sensitive genetic background of heterozygotes but never leads to a stronger expressivity or gastrulation defects ( Supplementary Figure 8) . A potential explanation for the discrepancy with morpholino-based findings could be that our zebrafish alleles are not null alleles and residual Bcl9/9l products possibly rescue the phenotype. We further cannot rule out genetic compensation during gastrulation for bcl9 by bcl9l and vice versa 41 , despite absence of such an effect at later stages in our double-mutants ( Figure 1 ). Nonetheless, the genetic evidence together with chemical perturbation of the Bcl9/9l-HD2 by LH-4-20 49 support only a tissue-specific contribution of BCL9-tethered Pygo to β-cateninbased Wnt signaling in zebrafish development.
Both zebrafish and mouse embryos with perturbed BCL9 and Pygo broadly maintain transcriptional activity of β-catenin (Figures 3 and 4 ). Nonetheless, following our observation of cardiac defects in interaction-perturbing Bcl9 and Pygo mutants, transcriptome analysis ( Figure 6 ) and chromatin occupancy of β-catenin and PYGO ( Figure 7 ) uncovered a collection of cardiac and pharyngeal genes sensitive to disruption of the PYGO-BCL9-β-catenin complex. Among these, we found common pan-β-catenin target genes, including Axin2 and Lef1. Importantly, however, we predominantly uncover genes associated with tissue-specific functions ( Figures 7) . Our data support models of canonical Wnt target gene expression by context-dependent nuclear β-catenin interactions, and define BCL9 and Pygo proteins as selectively required β-catenin interactors in vertebrate heart development. Of note, cardiac defects in mice such as AV valve malformations lead to embryonic lethality between 13.5 and 16.5 dpc 68,69 , suggesting that the cardiac malformations could indeed cause the lethality of Pygo1/2-mutant and Bcl9/9l-ΔHD1 embryos.
The limb and additional skeletal phenotypes observed in our mutants deserve detailed future analysis. Our findings further emphasize that BCL9 and Pygo cannot be strictly defined as core components of canonical Wnt pathway; if their mandatory contribution to canonical Wnt signaling in Drosophila represents an ancestral function or a specialization warrants further investigation.
Multiple contributions of Wnt signaling during vertebrate heart formation have previously been uncovered: waves of activation and inhibition of Wnt/β-catenin signaling are essential for the balance between proliferation versus differentiation of cardiac progenitors [17] [18] [19] 70, 71 , for endocardial invagination and EMT during valve formation, and in and neural crest cell migration into the heart 15 46 . In this context, BCL9 and Pygo contribute to orchestrating the downstream expression of selected mesodermal heart and neural crest regulators, including Msx1, Prrx1, and Six2, as further emphasized by β-catenin and PYGO2 binding in the vicinity of these loci (Figure 7g ). Of note, individual deregulation of each of these factors can cause specific developmental heart defects: Msx1, Prrx1, and Six2 were previously implicated in CNC cells proliferation, in SHF-dependent OFT formation, and in EMT during AV valves formation, respectively 58, 61, 75 . Their downregulation, in turn, causes the subsequent deregulation of additional critical factors for heart morphogenesis, including Hand2, Pitx2, as well as members of the FGF signaling cascade ( Supplementary Table 3 ) 76, 77 . Notably, Pitx2, a seemingly secondary target of Wnt signaling in this context, is involved in septation and left-right patterning of the heart, as well as in modulation of a Tbx5-dependent GRN in heart homeostasis 64 . Loss-of-function of Hand2 and Pitx2 is individually associated with several heart defects reminiscent of the phenotypes caused by perturbation of the PYGO-BCL9-β-catenin complex 4, 5, 13, 16 . These findings indicate that canonical Wnt/β-catenin signaling modulates a particular cardiac GRN via the direct activation of transcription factor genes including Msx1, Prrx1, Six2, and possibly Hand2 using the context-specific βcatenin co-factors BCL9 and PYGO.
An imbalance of BCL9 and Pygo levels both by loss and by overexpression affects β-catenin-dependent canonical Wnt readouts in several systems. In Drosophila, misexpression of a lgs variant that fails to bind β-catenin/Armadillo impairs canonical Wnt signaling, as does overexpression of BCL9 in human cell culture 22, 78 . Altering the level of BCL9 in Xenopus leads to gastrulation defects that are reminiscent of defects in β-catenin function during organizer formation 26 . These effects can be explained by sequestration of Pygo and β-catenin by elevated BCL9 levels, resulting in a net loss of functional Pygo-BCL9-β-catenin complexes akin to reduced or lost BCL9. In non-syndromic, sporadic cases of human CHD (with or without additional extra-cardiac phenotypes), copy number gains and losses have repeatedly been found in the genomic region 1q21.1 that includes the BCL9 locus [32] [33] [34] [35] [36] [37] [38] . CNVs that lead to either loss or gain of BCL9 copies could perturb the sensitive balance of the PYGO-interacting co-activator function of BCL9 with βcatenin during human heart development. Furthermore, mutations in BCL9L, including changes in the HD1, have been genetically linked in a small pedigree to heterotaxia (HTX) with congenital cardiac malformations including ventricular and atrial septal defects 39 . Our genetic and functional data reveal a causative connection between varying Wnt/β-catenin signaling levels by mutations in Bcl9 and Pygo with developmental heart defects in both zebrafish and in mice; therefore, our findings indicate that CNVs of, or mutations in, BCL9 and BCL9L contribute to the etiology of human CHDs through tissue-specific perturbation of canonical Wnt signaling.
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Methods
Zebrafish husbandry and transgenic strains
All zebrafish embryos were raised and maintained in E3 medium at 28.5°C without light cycle essentially as previously described 79 . All experiments were performed on embryos and larvae up to 5 dpf and older larvae only kept for raising mating pairs in agreement with procedures mandated by the veterinary office of UZH and the Canton of Zürich. Embryo staging was done according to morphological characteristics corresponding to hours post fertilization (hpf) or days post fertilization (dpf) as described previously 80 .
Previously established transgenic zebrafish lines used for this study include Tg(-6.35drl:EGFP) 81 and Tg(7xTCF-Xla.Siam:nlsmCherry) ia5 48 . 
CRISPR-Cas9 mutagenesis
Crispants were raised to adulthood and crossed to wildtypes to make F1 germline mutants. All analyses and experiments were taken out on F2 mutant generations and beyond. Genotyping primers were designed to either amplify target regions of mutated alleles that were subsequently analyzed via sequencing (for pygo1∆1) or high-percentage gel electrophoresis (for bcl9 ∆29 ) or allele-specific primers were designed to bind to mutated vs. wildtype sequences specifically (for bcl9l ∆4 and pygo1 ∆5 ). Primers used were: i) bcl9 5'-GGTGGAAAGCCCCAACTCC-3' (fwd), 5'-CGTGTGCCAACTGCTGGTGG-3' (rev); ii) bcl9l 5'-CACTTGCAGGTGCTGCATGG-3' (fwd), 5'-CTTTGAGATTTAGGTGTGCCGG-3' (rev); iii)
rev). Genotyping results
were analyzed and alleles visualized using CrispRVariantsLite 84 .
Chemical treatments
Wildtypes, Tg(7xTCF-Xla.Siam:nlsmCherry) ia5 , and embryos obtained from bcl9 ∆29 heterozygous incrosses were treated with LH-2-40 to globally perturb Bcl9∆HD2-beta-catenin interaction at the respective developmental stages. LH-2-40 was kindly received from the laboratory of Dr. Haitao Ji (Moffitt Cancer Center, Tampa/FL, USA). Single-use LH-2-40 stocks were kept at a concentration of 100 mM in DMSO at -80°C and thawed and diluted in E3 to a working concentration indicated in individual experiments directly before administration to the embryos.
Alcian Blue staining
Wildtype, bcl9, and pygo1/2 mutant larvae were fixed in 4% Paraformaldehyde (PFA) overnight at 4°C and after washing in 0.1% PBS-Tween (PBST) stained in Alcian blue staining solution (0.1 g Alcian blue, 70 mL ethanol, 30 mLl glacial acetic acid) overnight at room temperature. Embryos were washed in Ethanol and transferred through an Ethanol series to PBST and subsequently bleached in hydrogen peroxide (3% H2O2 in 1% KOH in PBS) for 1 hour or until pigments of specimens became transparent.
Whole-mount in situ hybridization
First-strand complementary DNA (cDNA) was generated from pooled zebrafish RNA isolated from different developmental stages using Superscript III First-Strand Synthesis kit (Invitrogen). DNA templates were generated using first-strand cDNA as PCR template and following primers Embryos were fixed in 4% PFA overnight at 4°C, transferred into 100% methanol and stored at -20°C.
ISH of whole mount zebrafish embryos was performed essentially according to standard protocols 85 .
Microscopy and data processing
Brightfield (BF), basic fluorescence, and ISH imaging was performed using a Leica M205FA equipped with a DFC450 C camera. Detailed fluorescent embryo imaging of drl:EGFP-expressing bcl9 mutants was performed by Single Plane Illumination Microscopy (SPIM) with a Zeiss Lightsheet Z.1 microscope. Prior to imaging, embryos were embedded in a rod of 1% low melting agarose in E3 with 0.016% Ethyl 3aminobenzoate methanesulfonate salt (Tricaine, Sigma) in a 50 µL glass capillary.
Image processing was done with Leica LAS, Zeiss Zen Black, ImageJ/Fiji and Adobe Photoshop and
Illustrator CS6 according to image-preserving guidelines to ensure unbiased editing of the acquired image data. Quantitative data analysis was performed using GraphPad Prism 5.0. Data are presented as mean ± SEM. A lower case "n" denotes the number of embryos, while a capital "N" signifies the number of replicates. To perform SPIM on embryonic mouse heart, tissue samples were extracted at 13.5 dpc, embedded in low melting agarose, dehydrated, and cleared using Benzyl Alcohol/ Benzyl Benzoate (1:2).
3D optical sectioning of the anatomy of the samples was performed with a Qls-Scope light sheet microscopy system (Planelight S.L., Madrid, Spain) by measuring autofluorescence with a 5x objective where signal was optimal, in this case exciting at 532 nm and collecting emission at 590 +/-40 nm.
Samples where imaged from two opposing views and combined to form a single volumetric image with an isotropic voxel size of 2.6 m.
Mouse lines
Knock-in mutants in Bcl9 and Bcl9l were generated by standard techniques, as previously described 29 
Histological analysis
Embryos between day 9.5 and 14.5 dpc were fixed overnight in 4% paraformaldehyde at 4°C, dehydrated and embedded in paraffin. Sections were stained with haematoxylin and eosin for histological analysis.
The same paraffin embedded material was sectioned under RNase free conditions for in situ hybridization.
Mouse in situ hybridization
Whole-mount in situ hybridization (ISH) was performed as described previously 86 . Digoxigenin-labeled probes (Roche) were detected by enzymatic color reaction using alkaline phosphatase-conjugated antidigoxigenin Fab fragments (1:1000, Roche) and BM purple alkaline phosphatase substrate (Roche).
Digoxigenin-labeled RNA probes were detected with peroxidase-conjugated anti-digoxigenin Fab fragments (1:500, Roche) followed by fluorescence detection using Tyramide Signal Amplification (PerkinElmer). Mouse antisense RNA probes were as described in supplementary materials. Quantitative RNA in situ hybridization was performed using RNAscope 2.5 (ACD) according to manufacturers' instruction. Mean intensity measurements were performed using ImageJ.
Intracardiac injection of India ink
For the analysis of the cardiovascular system, india ink was injected into the left ventricle of mouse embryos at 14.5 dpc, using a finely drawn glass pipette, right after embryonic dissection when the heart was still beating. The embryos were subsequently fixed in 4% paraformaldehyde and hearts were dissected for the anatomic examination.
RNA sequencing
Zebrafish samples (polyA selection): Zebrafish embryos from bcl9 ∆29/wt crosses were dissected at 54 hpf: a cut was made between the anterior part of the embryo (containing the head, pharyngeal and cardiac structures) and the posterior part starting from the beginning of the yolk extension. The anterior tissues were directly snap-frozen in liquid nitrogen in single tubes of PCR 8-tube strips. The posterior trunks and tails were transferred in 50 mM NaOH and genomic DNA was extracted with alkaline lysis. Single embryos were genotypes using the target sequence primers listed above and PCR products were separated through high-percentage gel electrophoresis leading to a separation of the wildtype allele and mutant allele with the following outcome: i) a low running band in bcl9 ∆29 mutants; ii) a high running band in wildtypes;
iii) two bands in bcl9 ∆29/wt heterozygous mutants. All snap-frozen anterior parts of bcl9 ∆29 mutants and of wildtypes were pooled in two separate tubes and RNA isolation performed with the RNeasy Plus Mini Kit (Qiagen). The whole procedure was repeated for a total of three clutches making three independent replicates.
The TruSeq mRNA stranded kit from Illumina was used for the library preparation with 250 ng of total 
qRT-PCR
Quantitative real-time SYBR Green-based PCR reactions were performed in triplicate and monitored with the ABI Prism 7900HT system (Applied Biosystem).
Chromatin Immunoprecipitation (ChIP)
Ca. 200 branchial arches of E10.5 embryos were dissected and dissociated to a single cell suspension. 
Cells
Branchial arch explants
Pharyngeal apparatus was dissected in PBS and resuspended in digestion mix (0.5mg collagenase/ml, 0.1% Trypsin), incubated at 37 °C for 15min. Tissue digestion was inactivated with 750ul of DMEM 10%
FCS and cells were plated in fibronectin coated wells in medium according to Zhao et al., 2006 87 .
Accession codes
ChIP-seq and RNA-seq reads are being deposited in the Gene Expression Omnibus (GEO) repository.
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